A Review of Perspectives on the Use of Randomization in Phase II Oncology Trials. (2019)

First Author: Grayling MJ
Attributed to:  Adaptive Clinical Trials funded by MRC


No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/jnci/djz126

PubMed Identifier: 31218346

Publication URI: http://europepmc.org/abstract/MED/31218346

Type: Journal Article/Review

Volume: 111

Parent Publication: Journal of the National Cancer Institute

Issue: 12

ISSN: 0027-8874